Paglalarawan

Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology with many potential applications in biology and medicine research. Nanomaterials offer great possibilities for biomedical applications because of their high flexibility, stability, modular character, and biocompatibility. The global nanoparticles in biology and medicine market in terms of revenue is set to grow by US$ 39 bilyon sa panahon ng 2021-2027, lumalaki sa isang compound taunang rate ng paglago (CAGR) ng mga 7.4% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.

Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2017-2020 at forecast na 2027 covering key market aspects like sales value for nanoparticles in biology and medicine. The global nanoparticles in biology and medicine market is segmented on the basis of type, rehiyon. Ayon sa uri, it is categorized into biotechnology, drug development & formulation, and drug delivery systems. The drug delivery systems segment held the largest market share in 2020. Gayunpaman, the drug development & formulation segment is expected to witness the highest CAGR during the forecast period. By region, the nanoparticles in biology and medicine market is divided into North America, Asya Pasipiko, Europa, and Rest of the World (ROW). Sa 2020, the North America region held the largest share of the market, and the Asia Pacific region is anticipated to register the highest CAGR during 2021 sa 2027.

The report has profiled some of the key players of the market such as Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck KGaA, NanoCarrier Co. Ltd., Novartis AG.

Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the nanoparticles in biology and medicine market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.

Saklaw ng Ulat

Uri ng: biotechnology, drug development & formulation, and drug delivery systems
Rehiyon: Hilagang Amerika, Asya Pasipiko, Europa, and Rest of the World (ROW)
Mga Taon na Itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2017 sa 2027

Mga Pangunahing Benepisyo para sa mga Stakeholder

Get a comprehensive picture of the global nanoparticles in biology and medicine market
Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan
Understand what the future of the global nanoparticles in biology and medicine market looks like
Kilalanin ang mapagkumpitensya na landscape at window ng pagkakataon

Talaan ng mga Nilalaman

1. Kahulugan ng Market
2. Metodolohiya ng Pananaliksik
3. Market Data & Outlook
3.1 Halaga ng Market
3.2 Pagtataya ng Halaga sa Market
4. Nanoparticles in Biology and Medicine Market by Type
4.1 Bioteknolohiya
4.2 Drug Development & Formulation
4.3 Drug Delivery Systems
5. Nanoparticles in Biology and Medicine Market by Region
5.1 Hilagang Amerika
5.2 Asya Pasipiko
5.3 Europa
5.4 Rest Of The World (Row)
6. Mga Profile ng Kumpanya
6.1 Bristol-Myers Squibb Company
6.2 F. Hoffmann-La Roche Ltd.
6.3 GlaxoSmithKline plc
6.4 Merck KGaA
6.5 NanoCarrier Co., Ltd.
6.6 Novartis AG
7. Apendiks
7.1 Tungkol sa StrategyHelix
7.2 Pagtanggi